Mach7 Technologies Limited (ASX:M7T)
Australia · Delayed Price · Currency is AUD 0.4000
-0.0150 (-3.61%)
Feb 4, 2026, 3:30 PM AEST
Mach7 Technologies Revenue
In the fiscal year ending June 30, 2025, Mach7 Technologies had annual revenue of 33.79M AUD with 16.00% growth. Mach7 Technologies had revenue of 16.05M in the half year ending June 30, 2025, with 17.56% growth.
Revenue
33.79M
Revenue Growth
+16.00%
P/S Ratio
2.89
Revenue / Employee
n/a
Employees
58
Market Cap
97.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 33.79M | 4.66M | 16.00% |
| Jun 30, 2024 | 29.13M | -937.12K | -3.12% |
| Jun 30, 2023 | 30.06M | 3.67M | 13.92% |
| Jun 30, 2022 | 26.39M | 7.35M | 38.57% |
| Jun 30, 2021 | 19.04M | 97.00K | 0.51% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cogstate | 80.98M |
| Alcidion Group | 40.79M |
| Beamtree Holdings | 28.60M |
| ImExHS | 26.32M |
| PharmX Technologies | 7.53M |
| Vitasora Health | 3.71M |
| PainChek | 3.36M |
| Emyria | 1.39M |
Mach7 Technologies News
- 2 months ago - Mach7 Technologies Limited (TDMMF) Shareholder/Analyst Call Transcript - Seeking Alpha
- 2 months ago - Mach7 Technologies Limited (TDMMF) Shareholder/Analyst Call - Slideshow - Seeking Alpha
- 3 months ago - Mach7 Technologies Limited (TDMMF) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Mach7 Technologies Limited 2026 Q1 - Results - Earnings Call Presentation - Seeking Alpha